TYP 5.00% 2.1¢ tryptamine therapeutics limited

Ann: Exopharm LEAP Technology - Second Commercial Collaboration, page-9

  1. 16,819 Posts.
    lightbulb Created with Sketch. 356
    Exactly.

    The key point.

    If exosomes make delivery easier, faster and more reliable that's a total license to print money.

    The more collaborations , feasibility studies and trials they get involved in the closer they get.

    No one else is doing it.
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
0.001(5.00%)
Mkt cap ! $22.87M
Open High Low Value Volume
2.0¢ 2.1¢ 2.0¢ $6.632K 320.5K

Buyers (Bids)

No. Vol. Price($)
1 446080 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 29839 1
View Market Depth
Last trade - 16.10pm 02/08/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.